14 results
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
of Antianginal Drugs ... #Antianginal #Medications ... #Cardiology #Pharmacology ... #Management #Therapy ... #Table #Overview
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Brief Overview of ... 4/11/2020 #Drugs ... #Medications #Treatment ... #Table #Management ... #MGH
Summary table of mechanism of action, side effect and contraindications of commonly used drugs for tuberculosis.
Summary table of ... commonly used drugs ... #pharmacology #medications ... #table #management ... #overview #tuberculosis
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. 

#pharmacology
Summary table of ... used diabetic drugs ... #pharmacology #dm2 ... #diabetes #medications ... #overview #management
Pharmacotherapy for Migraine Prophylaxis 

Who is indicated for migraine prophylaxis? Patients who experience more than 3
Pharmacotherapy for Migraine ... indicated for migraine ... #Prophylaxis #Medications ... #Table #Pharmacology ... #Management #Neurology
Migraine Treatment Overview

 • What is a Migraine?
 • Pathophysiology
 • Common Migraine Triggers
 • Diagnosis
Overview • ... Diagnosis • Non-Drug ... #Treatment #management ... #pharmacology # ... prophylaxis #neurology
Triptan Selection - Migraine Management
Choosing triptans:
 • Reponse to given triptan do not predict to others
Triptan Selection - Migraine ... Management Choosing ... month to avoid medication-overuse ... #Management #treatment ... #neurology #pharmacology
Immunosuppression in Transplantation
Induction (I):
 - Basiliximab (Simulect)
 - Alemtuzumab (Campath)
 - Rituximab
 - Anti-Thymocyte Globulin (ATG)
Induction
Immunosuppressive #Medications ... #Pharmacology # ... Table #Drugs #Induction ... #Maintenance #Management ... #Nephrology #Renal
Migraine Prevention and Prophylaxis
Who to Consider: 
 • ≥ 4 significant headaches or migraine attacks/month
 •
days/month • Medication-overuse ... Severe/DisabIing symptoms ... Preventative Medications ... #prophylaxis #neurology ... #headache #management
Aimovig (Erenumab)
Mechanism: Calcitonin Gene-related Peptide Receptor Antagonist 
Indication: Preventive Treatment of Migraines:
Dosing: 70 mg SQ monthly,
Receptor Antagonist Indication ... : Dosing: 70 mg ... increase to 140 mg ... reported this drug ... #Neurology #Pharmacology